Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
7.94
-0.05 (-0.63%)
At close: Dec 19, 2025, 4:00 PM EST
7.94
0.00 (0.00%)
After-hours: Dec 19, 2025, 4:00 PM EST
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $140.15 million as of December 19, 2025. Its market cap has increased by 160.09% in one year.
Market Cap
140.15M
Enterprise Value
132.85M
1-Year Change
160.09%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $140.15M, a decrease of -55.11%. That is a compound annual growth rate of -26.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 139.63M | 154.04% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |